On February 14, 2023 Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, reported that members of its management team will participate in the upcoming investor conferences (Press release, Syndax, FEB 14, 2023, View Source [SID1234627182]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A fireside chat at the Citi 2023 Virtual Oncology Leadership Summit at 2:00 p.m. ET on Tuesday, February 21, 2023
A fireside chat at Cowen’s 43rd Annual Healthcare Conference at 9:10 a.m. ET on Monday, March 6, 2023 in Boston, MA
A panel discussion on leukemia at Cowen’s 43rd Annual Healthcare Conference at 12:50 p.m. ET on Wednesday, March 8, 2023 in Boston, MA
A fireside chat at the Barclays Global Healthcare Conference at 10:45 a.m. ET on Wednesday, March 15, 2023 in Miami, FL
A live webcast of the fireside chats can be accessed from the Investor section of the Company’s website at www.syndax.com, where a replay of the events will also be available for a limited time.